Methylation of the 3p22 region encompassing MLH1 is representative of the CpG island methylator phenotype in colorectal cancer

Early onset MSI-H colon cancer with MLH1 promoter methylation, is there a genetic predisposition?

(2010) Eddy HJ van Roon et al.   BMC CANCER

Detection of MGMT Promoter Methylation in Normal Individuals Is Strongly Associated with the T Allele of the rs16906252 MGMT Promoter Single Nucleotide Polymorphism

(2009) I. L.M. Candiloro et al.   Cancer Prevention Research

Implementation of Novel Pyrosequencing Assays to Screen for Common Mutations of BRAF and KRAS in a Cohort of Sporadic Colorectal Cancers

(2009) Deborah Packham et al.   DIAGNOSTIC MOLECULAR PATHOLOGY

Clinical Implications of Microsatellite Instability andMLH1Gene Inactivation in Sporadic Insulinomas

(2009) Mei Mei et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

MGMT methylation is associated primarily with the germline C>T SNP (rs16906252) in colorectal cancer and normal colonic mucosa

(2009) Nicholas J Hawkins et al.   MODERN PATHOLOGY

DLEC1 and MLH1 promoter methylation are associated with poor prognosis in non-small cell lung carcinoma

(2008) T J Seng et al.   BRITISH JOURNAL OF CANCER

TheMLH1−93 G>A promoter polymorphism and genetic and epigenetic alterations in colon cancer

(2008) Wade S. Samowitz et al.   GENES CHROMOSOMES & CANCER

The CpG Island Methylator Phenotype Correlates with Long-Range Epigenetic Silencing in Colorectal Cancer

(2008) P. Karpinski et al.   MOLECULAR CANCER RESEARCH